ロード中...
CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy
CTLA-4 is a co-receptor on T-cells that controls peripheral tolerance and the development of autoimmunity. Immune check-point blockade (ICB) uses monoclonal antibodies (MAbs) to block the binding of inhibitory receptors (IRs) to their natural ligands. A humanized antibody to CTLA-4 was first approve...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6277866/ https://ncbi.nlm.nih.gov/pubmed/30542345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02737 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|